Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ruwani Dissanayake has a total of 68 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Neurodevelopmental regression is associated with chromatin, transcriptional and immune dysregulation which can be reversed by HDAC inhibition

    by Russell Dale, Hiroya Nishida, Velda Han, Brooke Keating, Katherine Zyner, Jessica Hayes, Brian Gloss, Nader Aryamanesh, Pinki Dey, Lee L Marshall, et al.

    Neurodevelopmental regression in children, including autistic regression, is often associated with inconclusive diagnostic investigations, leaving the underlying pathophysiology poorly understood. We conducted peripheral blood multi-omic profiling in 15 children with neurodevelopmental regression (median age 9 (4-14) years, 60% males, 7 had developmental issues prior to regression), and 18 healthy controls (median age 12 (7-16) years, 56% males). Our comprehensive analysis included peripheral blood bulk RNA sequencing (8 regression vs. 8 controls), single-cell RNA sequencing (two cohorts of 4 regression vs. 4 controls), bulk proteomics (4 regression vs. 4 controls), phosphoproteomics (4 regression vs. 4 controls), and analysis of transposase-accessible chromatin (ATAC) sequencing (8 regression vs. 6 controls). Despite clinical heterogeneity, we identified convergent pathophysiological processes, including dysregulated epigenetic pathways (chromatin remodelling, histone modifications, transcription factors) and immune responses, as well as downregulated ribosomal and translational pathways. Our data supports a predisposition to a heterochromatin (closed) state in patients. We therefore treated patient PBMCs with in vitro histone deacetylase inhibitor, givinostat, to modulate RNA expression (1 regression vs. 1 control). Through single-cell RNA sequencing, we showed that in vitro givinostat reversed the dysregulated ribosomal and translational pathways, and downregulated immune pathways in patient PBMCs. Disruptions in epigenetic, immune and translational processes may arise from complex genetic and environmental interactions in children with neurodevelopmental regression. Therapies that target immune dysregulation or epigenetic modifications may represent effective treatment options for these individuals.

  • Open Access

    IV Immunoglobulin Is Associated With Epigenetic, Ribosomal, and Immune Changes in Pediatric Acute-Onset Neuropsychiatric Syndrome

    by Velda X. Han, Hiroya Nishida, Brooke A. Keating, Brian S. Gloss, Xianzhong Lau, Ruwani Dissanayake, Jessica Hayes, Shekeeb S. Mohammad, Shrujna Patel, Russell C. Dale

    Pediatric acute-onset neuropsychiatric syndrome (PANS) is characterized by infection-provoked abrupt-onset obsessive compulsive disorder (OCD) and neurodevelopmental regression. Owing to the neuroimmune hypothesis, we investigated the effects of IV immunoglobulin (IVIg) on cell-specific gene expression. Single-cell RNA sequencing of peripheral immune cells was performed in 5 children with PANS (median age 8 (5.5-16) years), before and after administering open-label IVIg, compared with 4 controls (median age 13.5 [IQR 12-15] years). The index PANS event (age 1.8-13 years) involved abrupt eating restriction (n = 5), developmental regression (n = 4), and OCD (n = 3). A total of 144,470 cells were sequenced and clustered into 11 cell types. Children with PANS before IVIg compared with controls showed downregulated immune pathways (defense response, innate immunity, secretory granules) in most cell types, with natural killer (NK) cells showing upregulated immune pathways (response to corticosteroid), supporting baseline "immune dysregulation." Ribosomal pathways were upregulated in neutrophils and CD8 T cells but downregulated in NK cells. In children with PANS after IVIg, the baseline immune and ribosomal pathway abnormalities were reversed and histone modification pathways (histone methyltransferase, chromatin) were downregulated in neutrophils and NK cells. We propose that PANS is an epigenetic immune brain disorder with cellular epigenetic, ribosomal, and immune dysregulation. Epigenetic and immune-modulating therapies, such as IVIg, may have disease-modifying effects.


  • Open Access

    Epigenetic, ribosomal, and immune dysregulation in paediatric acute-onset neuropsychiatric syndrome

    by Velda X. Han, Sarah Alshammery, Brooke A. Keating, Brian S. Gloss, Markus J. Hofer, Mark E. Graham, Nader Aryamanesh, Lee L. Marshall, Songyi Yuan, Emma Maple-Brown, et al.

    Paediatric Acute-Onset Neuropsychiatric Syndrome (PANS) is characterised by abrupt onset obsessive compulsive disorder and regression in neurodevelopmental skills, triggered by infection or stress. Whether PANS is a distinct entity or part of a neurodevelopmental spectrum is uncertain, and its pathophysiology remains unclear. We show that children with PANS (n = 32) and other non-PANS (n = 68) neurodevelopmental disorders (total n = 100) have higher reported early childhood infections and a loss of previously acquired developmental skills compared to neurotypical controls (n = 58). Children with PANS have normal routine immune testing, however bulk RNA-sequencing (PANS n = 20 vs controls n = 15) revealed upregulated pathways in ribosomal biogenesis and RNA methyltransferases, and downregulated pathways in diverse cellular functions such as mitochondrial activity, cell signalling, endocytosis, and immune responses. Single-cell RNA-sequencing (PANS n = 2 vs controls n = 2) confirmed these findings but showed heterogeneity across immune cell types. Toll-like receptor stimulation assay using peripheral blood mononuclear cells revealed reduced TNF and interleukin-6 responses in PANS patients (n = 7) compared to controls (n = 7). RNA sequencing before and after intravenous immunoglobulin treatment in PANS patients (n = 9 vs controls n = 10) revealed reversal of the dysregulated ribosomal, epigenetic, and cell signaling pathways. Given the central role of the immune system in synaptic pruning and neurodevelopment, these insights provide rationale for novel epigenetic and immune modulating therapies to optimize neurodevelopmental trajectories and minimize neuropsychiatric impairment in PANS.


  • Open Access

    Single‐Cell RNA Seq in Sydenham Chorea Shows B Cell HLA‐DR/DQ Upregulation and Plasma Cell Proteasomal Activation

    by Velda X. Han, Brooke A. Keating, Brian S. Gloss, Xianzhong Lau, Ruwani Dissanayake, Hiroya Nishida, Jessica Hayes, Shrujna Patel, Shekeeb S. Mohammad, Russell C. Dale

    The pathogenesis of Sydenham chorea remains unclear. We report a 10‐year‐old girl presenting with subacute chorea and mild carditis following Streptococcal throat infection. Single‐cell RNA sequencing on 30,794 peripheral immune cells from the patient and two sex‐matched controls revealed nine immune cell clusters. We found up‐regulated antigen processing pathways in B cells, monocytes, and eosinophils, enriched by HLA genes, particularly HLA‐DRB5 and HLA‐DQB1 , and immunoglobulin ( IGH ) genes in B cells. Up‐regulated proteasomal pathways in plasma cells were enriched by PSM genes. These insights support the B cell‐mediated autoantibody hypothesis in Sydenham chorea. We highlight the potential of scRNA‐seq in rare diseases to inform targeted therapies.


  • Open Access

    Epigenetic, ribosomal, and immune dysregulation in Paediatric Acute-Onset Neuropsychiatric Syndrome

    by Velda X Han, Sarah Alshammery, Brooke A Keating, Brian S Gloss, Markus J Hofer, Mark E Graham, Nader Aryamanesh, Lee L Marshall, Songyi Yuan, Emma Maple-Brown, et al.

    Paediatric Acute-Onset Neuropsychiatric Syndrome (PANS) is characterised by abrupt onset obsessive compulsive disorder and regression in neurodevelopmental skills, triggered by infection or stress. Whether PANS is a distinct entity or part of a neurodevelopmental spectrum is uncertain, and its pathophysiology remains unclear. We show that children with PANS (n=32) and other non-PANS (n=68) neurodevelopmental disorders (total n=100) have higher reported early childhood infections and a loss of previously acquired developmental skills compared to neurotypical controls (n=58). Children with PANS have normal routine immune testing, however bulk RNA-sequencing (PANS n=20 vs controls n=15) revealed upregulated pathways in ribosomal biogenesis and RNA methyltransferases, and downregulated pathways in diverse cellular functions such as mitochondrial activity, cell signalling, endocytosis, and immune responses. Single-cell RNA-sequencing (PANS n=2 vs controls n=2) confirmed these findings but showed heterogeneity across immune cell types. Toll-like receptor stimulation assay using peripheral blood mononuclear cells revealed reduced TNF and interleukin-6 responses in PANS patients (n=7) compared to controls (n=7). RNA sequencing before and after intravenous immunoglobulin treatment in PANS patients (n=9 vs controls n=10) revealed reversal of the dysregulated ribosomal, epigenetic, and cell signaling pathways. Given the central role of the immune system in synaptic pruning and neurodevelopment, these insights provide rationale for novel epigenetic and immune modulating therapies to optimize neurodevelopmental trajectories and minimize neuropsychiatric impairment.


  • Open Access

    Intravenous immunoglobulin has epigenetic, ribosomal, and immune effects in Paediatric Acute-Onset Neuropsychiatric Syndrome

    by Velda X Han, Hiroya Nishida, Brooke A Keating, Brian S Gloss, Xianzhong Lau, Ruwani Dissanayake, Jessica Hayes, Shekeeb S Mohammad, Shrujna Patel, Russell C Dale

    Paediatric acute-onset neuropsychiatric syndrome (PANS) is characterised by infection-provoked abrupt and dramatic onset of obsessive compulsive disorder (OCD) or eating restriction, along with neurodevelopmental regression. Although the aetiology of PANS remains uncertain, due to a prevailing neuroimmune hypothesis some children receive the immune modulator intravenous immunoglobulin (IVIg). Using single-cell RNA sequencing of peripheral immune cells, we examined gene expression in five children with PANS (mean age 10.2 years, range 5–17, 60% male) who were receiving open-label IVIg. Maternal autoimmunity (n=3) and familial neurodevelopmental/neuropsychiatric disorders (n=5) were present. The index PANS event occurred age 1.8–13 years, characterised by abrupt eating restriction (n=5), developmental regression (n=4), and OCD (n=3). Single-cell RNA sequencing (144,470 cells) was performed in five patients pre- and post-IVIg, and four controls (mean age 13.5 years, range 11–16, 50% male). In PANS pre-IVIg compared to neurotypical controls, there were downregulated immune pathways (defense response, innate immunity, secretory granules) in most cell types. However, NK cells exhibited upregulated immune pathways (response to corticosteroid), supporting a baseline ‘immune dysregulation’. In PANS pre-IVIg compared to controls, ribosomal pathways were upregulated in neutrophils and CD8 T cells, but downregulated in NK cells. Post-IVIg, the previously downregulated immune pathways were upregulated in most cell types, and the baseline ribosomal pathway abnormalities were reversed. Additionally, histone modification pathways (histone methyltransferase, chromatin) were downregulated in neutrophils and NK cells post-IVIg. We propose PANS is an epigenetic immune-brain disorder with cellular epigenetic, ribosomal, and immune dysregulation. Therefore, epigenetic and immune-modulating therapies, such as IVIg, may have a critical role in treating this disabling disorder. Highlights: Five children with PANS receiving monthly IVIg who had clinical benefit were studied Three young boys had a regressive (autistic) phenotype, whereas the older two girls had OCD Single-cell RNA sequencing showed epigenetic, ribosomal, and immune dysregulation in PANS IVIg treatment had epigenetic and immune-modulating effects in PANS IVIg altered gene expression of histone methyltransferase and chromatin genes


  • Open Access

    Cumulative pregnancy and postnatal environmental exposures impact social behaviour in male mice associated with epigenetic, ribosomal, and immune dysregulation

    by Morgan C Bucknor, Brooke A Keating, Velda X Han, Brian S Gloss, Pinki Dey, Nader Aryamanesh, Lee L Marshall, Mark E Graham, Ruwani Dissanayake, Xianzhong Lau, et al.

    Environmental exposures across critical developmental windows can significantly influence brain development and contribute to the pathogenesis of neurodevelopmental disorders (NDDs). Emerging clinical evidence suggests that cumulative environmental factors during early development result in more pronounced disease phenotypes in offspring. Here, we developed a ‘triple-hit’ model using C57Bl/6JAusb mice to examine the cumulative effects of antenatal social stress, antenatal chronic high-fat diet consumption, and postnatal poly(I:C) exposure on neurodevelopmental outcomes in offspring. Male ‘triple-hit’ offspring displayed autism-like social deficits and an overall increased susceptibility to neurodevelopmental behavioural alterations in adulthood compared to male non-stressed controls. Conversely, these behavioural changes were not observed amongst female ‘triple-hit’ offspring. Single-cell RNA (scRNA) transcriptomic and bulk proteomic sequencing were performed in male ‘triple-hit’ offspring across peripheral blood immune cells and brain tissue. scRNA sequencing in microglia, astrocytes, and oligodendrocytes revealed dysregulation in critical glial cell processes, ribosomal functions, and chromatin remodelling. Similar functional themes were observed across peripheral blood macrophages, neutrophils, and naïve B cells - displaying immune and ribosomal dysregulation at the transcriptional level. Proteomics pathway enrichment analyses revealed significantly reduced protein abundance in ribosomal biogenesis, translation, and chromatin remodelling functions in both peripheral blood immune cells and brain tissue. We also observed synaptic dysfunction in the blood and brain proteome. Overall, using our unique ‘triple-hit’ model, we demonstrate that multiple early life environmental exposures drive NDD-associated behaviours in a sex-specific manner; and is associated with overlapping central and peripheral molecular mechanisms that have clinical relevance to NDD pathogenesis.


  • Open Access

    Chromatin, transcriptional and immune dysregulation in children with neurodevelopmental regression

    by Hiroya Nishida, Velda X Han, Brooke A Keating, Katherine G Zyner, Brian Gloss, Nader Aryamanesh, Pinki Dey, Lee L Marshall, Erica Tsang, Sarah Alshammery, et al.

    Summary: Neurodevelopmental including autistic regression in children is often associated with inconclusive diagnostic investigations, leaving the underlying pathophysiology largely unexplored and poorly understood. To address this, we conducted peripheral blood multi-omics profiling in 15 children with neurodevelopmental regression (median age 9 (4-14) years, 60% males), and 15 healthy controls (median age 12 (7-16) years, 60% males). Our comprehensive analysis included bulk RNA sequencing (8 regression vs. 8 controls), single-cell RNA sequencing (two cohorts of 4 regression vs. 4 controls), bulk proteomics (4 regression vs. 4 controls), and phosphoproteomics (4 regression vs. 4 controls). Despite clinical heterogeneity, we identified convergent pathophysiological processes, including dysregulated pathways in epigenetic pathways (chromatin remodelling, histone modifications, transcription factors) and immune responses, as well as downregulated ribosomal and translational pathways. These disruptions in epigenetic, immune and translational processes may arise from complex genetic and environmental interactions, offering opportunities for therapeutic interventions that specifically target these pathways.


  • Open Access

    Application of Genomics to Understand Salt Tolerance in Lentil

    by Ruwani Dissanayake, Noel O.I. Cogan, Kevin F. Smith, Sukhjiwan Kaur

    Soil salinity is a major abiotic stress, limiting lentil productivity worldwide. Understanding the genetic basis of salt tolerance is vital to develop tolerant varieties. A diversity panel consisting of 276 lentil accessions was screened in a previous study through traditional and image-based approaches to quantify growth under salt stress. Genotyping was performed using two contrasting methods, targeted (tGBS) and transcriptome (GBS-t) genotyping-by-sequencing, to evaluate the most appropriate methodology. tGBS revealed the highest number of single-base variants (SNPs) (c. 56,349), and markers were more evenly distributed across the genome compared to GBS-t. A genome-wide association study (GWAS) was conducted using a mixed linear model. Significant marker-trait associations were observed on Chromosome 2 as well as Chromosome 4, and a range of candidate genes was identified from the reference genome, the most plausible being potassium transporters, which are known to be involved in salt tolerance in related species. Detailed mineral composition performed on salt-treated and control plant tissues revealed the salt tolerance mechanism in lentil, in which tolerant accessions do not transport Na+ ions around the plant instead localize within the root tissues. The pedigree analysis identified two parental accessions that could have been the key sources of tolerance in this dataset.


  • Open Access

    Development and Application of Image-Based High-Throughput Phenotyping Methodology for Salt Tolerance in Lentils

    by Ruwani Dissanayake, Hossein V. Kahrood, Adam M. Dimech, Dianne M. Noy, Garry M. Rosewarne, Kevin F. Smith, Noel O. I. Cogan, Sukhjiwan Kaur

    Soil salinity is a major abiotic stress in Australian lentil-producing areas. It is therefore imperative to identify genetic variation for salt tolerance in order to develop lentil varieties suitable for saline soils. Conventional screening methods include the manual assessment of stress symptoms, which can be very laborious, time-consuming, and error-prone. Recent advances in image-based high-throughput phenotyping (HTP) technologies have provided unparalleled opportunities to screen plants for a range of stresses, such as salt toxicity. The current study describes the development and application of an HTP method for salt toxicity screening in lentils. In a pilot study, six lentil genotypes were evaluated to determine the optimal salt level and the growth stage for distinguishing lentil genotypes using red–green–blue (RGB) images on a LemnaTec Scanalyzer 3D phenomics platform. The optimized protocol was then applied to screen 276 accessions that were also assessed earlier in a conventional phenotypic screen. Detailed phenotypic trait assessments, including plant growth and green/non-green color pixels, were made and correlated to the conventional screen (r = 0.55; p < 0.0001). These findings demonstrated the improved efficacy of an image-based phenotyping approach that is high-throughput, efficient, and better suited to modern breeding programs.